-
Nielsen’s Novel Approach to BAP1 and Mesothelioma
18 Aug 2025 22:53 GMT
… assumptions about the causes of malignant mesothelioma. While plaintiffs’ attorneys often … indicate the odds of spontaneous malignant mesothelioma among germline BAP1 mutant … Germline BAP1 mutations predispose to malignant mesothelioma, Nat. Genet. 2011, 43 …
-
Coffee-Based Nautral Mesothelioma Treatment Slows Cancer in Lab Tests
07 Aug 2025 20:14 GMT
… and cinnamic acid affected pleural mesothelioma.
During initial testing, … for developing new treatments for malignant mesothelioma.”
– Study authors
Find Alternative … Treatments for Mesothelioma
At Mesothelioma Hope, we understand that …
-
VT3989 Receives FDA Orphan Drug Designation for Mesothelioma
01 Aug 2025 16:15 GMT
… both pleural and non-pleural malignant mesothelioma.2
The study is … and tolerability in patients with malignant mesothelioma and other solid tumors harboring … advanced solid tumors enriched for malignant mesothelioma and other tumors with neurofibromatosis …
-
Vivace Therapeutics’ VT3989 for mesothelioma gains FDA Orphan Drug Designation
31 Jul 2025 12:09 GMT
… , VT3989, for the treatment of mesothelioma.
VT3989 is a transcriptional enhanced … for new, effective therapies for mesothelioma, an aggressive cancer with limited … both pleural and non-pleural malignant mesothelioma.
The clinical data gathered thus …
-
FDA Grants Orphan Drug Status to VT3989 for Mesothelioma Treatment
30 Jul 2025 19:00 GMT
… especially notable in patients with mesothelioma whose cancer progressed after … including pleural and non-pleural malignant mesothelioma.
The phase 1 study of … without NF2 mutations), non-pleural mesothelioma, pleural mesothelioma, and solid tumors with …
-
Vivace Therapeutics Announces Receipt of Orphan Drug Designation for VT3989 for Treatment of Mesothelioma
30 Jul 2025 11:51 GMT
… particularly notable in patients with mesothelioma who have failed chemotherapy and … refractory pleural and non-pleural malignant mesothelioma.
About Vivace Therapeutics, Inc.
… for-vt3989-for-treatment-of-mesothelioma-302516783.html
SOURCE Vivace …
-
Guest opinion: Mesothelioma registry could reduce misdiagnosis for veterans
25 Jul 2025 15:22 GMT
… 15 months. Recognizing mesothelioma and accurately determining … mesothelioma. Each year, there are approximately 2,500 new cases of malignant … pleural mesothelioma, the most … later reclassified.
Identifying mesothelioma and pinpointing its …
-
Preventing misdiagnosis through a national mesothelioma registry
17 Jul 2025 17:52 GMT
… prognosis is poor. A national mesothelioma registry could positively address these … toll of misdiagnosis Mesothelioma is an aggressive malignant tumor that develops in … , unlike other types of cancer, mesothelioma is incredibly challenging to diagnose …
-
Gene Expression After Asbestos Exposure Explains Development of Malignant Mesothelioma
27 May 2025 00:47 GMT
… investigating differential gene expression in malignant pleural mesothelioma (MPM) associated with documented … Carcinogenesis: Transcriptomic Signatures in Malignant Pleural Mesothelioma
Experimental and Molecular Pathology (2025 …
-
Leading Factor Driving The Malignant Mesothelioma Market In 2025: Rising Clinical R&D Efforts Driving Market Growth
13 May 2025 12:32 GMT
… =smp
What Drives The Malignant Mesothelioma Market Growth?
Further propelling … com/report/malignant-mesothelioma-global-market-report
Who Are … How Is The Malignant Mesothelioma Market Segmented?
The malignant mesothelioma market is segmented …